Update-(NYSE-MKT: XXII) – This week
If your new with us, you may have missed the initial coverage of XXII in December so I thought we would bring you up to speed.
December 14th, 2015 initial XXII report over 200 patents on the tobacco plant proprietary value – http://smallcapstreet.com/xxii/
January 20th, 2016 FDA meeting and modified risk labeling- http://smallcapstreet.com/xxii-fdameeting/
Should we see an FDA approval for modified risk labeling, the catalyst in our opinion becomes either a buyout by someone like British American Tobacco which already has a licensing deal with 22nd Century Group ( http://www.businesswire.com/news/home/20131001007113/en/British-American-Tobacco-Licenses-22nd-Century-Group ) or a joint venture with one of the bigger players in the industry.
If you have not read all of our coverage of XXII to date, please take a moment to do so.
This Week
There has been a lot of talk on the street about the opportunity in Small Caps this week. As I write this I can remember it being a big topic of discussion late Friday on CNBC.
As always we are scanning this sector daily looking for new opportunities for our group. We should be announcing a new profile soon, stay tuned.
VIP SMS/TEXT SERVICE
If you are receiving emails only, they can be unreliable. You may want to consider our free VIP SMS/text alert service by simply sending a text from your cell phone to the number 25827 in the message section just type in the word “Street”. Opt out anytime as always there is no obligation.
Thank you,
The Team